Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01GuruFocus · 12 hr ago
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 SGuruFocus · 12 hr ago
TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSOGuruFocus · 12 hr ago
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancerGuruFocus · 1 day ago
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trialGuruFocus · 1 day ago
IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCERGuruFocus · 1 day agoOneStream, Inc. delivers an integrated, adaptable software platform, enhanced with artificial intelligence capabilities, to clients across the United States and internationally. Their flagship offering, the Digital Finance Cloud platform, provides essential solutions for modern financial management. These include simplifying financial close and consolidation by automating various tasks and expertly navigating the intricate requirements and standards of financial reporting.